Viveve Medical Inc (VIVE)
0.0003
0.00 (0.00%)
USD |
OTCM |
May 09, 16:00
Viveve Medical Cash from Financing (TTM): 0.069M for Sept. 30, 2022
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
September 30, 2022 | 0.069M |
June 30, 2022 | 0.071M |
March 31, 2022 | 0.731M |
December 31, 2021 | 25.97M |
September 30, 2021 | 25.95M |
June 30, 2021 | 29.49M |
March 31, 2021 | 32.86M |
December 31, 2020 | 9.23M |
September 30, 2020 | 19.07M |
June 30, 2020 | 21.83M |
March 31, 2020 | 17.70M |
December 31, 2019 | 16.11M |
September 30, 2019 | 26.70M |
June 30, 2019 | 20.46M |
March 31, 2019 | 20.76M |
December 31, 2018 | 54.02M |
September 30, 2018 | 43.79M |
June 30, 2018 | 43.72M |
March 31, 2018 | 52.70M |
December 31, 2017 | 50.90M |
September 30, 2017 | 40.70M |
June 30, 2017 | 40.76M |
March 31, 2017 | 50.84M |
December 31, 2016 | 19.07M |
September 30, 2016 | 24.30M |
Date | Value |
---|---|
June 30, 2016 | 25.24M |
March 31, 2016 | 17.50M |
December 31, 2015 | 18.77M |
September 30, 2015 | 14.41M |
June 30, 2015 | 18.61M |
March 31, 2015 | 7.573M |
December 31, 2014 | 6.573M |
September 30, 2014 | 5.704M |
June 30, 2014 | 2.075M |
March 31, 2014 | 1.575M |
December 31, 2013 | 5.329M |
September 30, 2013 | 5.329M |
June 30, 2013 | 4.674M |
March 31, 2013 | 4.674M |
December 31, 2012 | 0.92M |
September 30, 2012 | 0.92M |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 3.605M |
September 30, 2011 | 3.605M |
June 30, 2011 | 3.605M |
March 31, 2011 | 3.605M |
December 31, 2010 | 0.00 |
September 30, 2010 | |
June 30, 2010 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.069M
Minimum
Sep 2022
32.86M
Maximum
Mar 2021
17.59M
Average
19.76M
Median
Cash from Financing (TTM) Benchmarks
HTG Molecular Diagnostics Inc | 1.729M |
Minerva Surgical Inc | 26.86M |
Stereotaxis Inc | 0.081M |
Electromed Inc | -0.128M |
Myomo Inc | 9.714M |